Will Tesla Stock Go Up In 2026?
EV giant Tesla (NASDAQ:TSLA) has, somewhat surprisingly, undershot the broader…
Sell
30
TELA Quote, Financials, Valuation and Earnings
Last price:
$1.13
Seasonality move
:
-15.82%
Day range:
$1.12 - $1.17
52-week range:
$0.86 - $3.10
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.66x
P/B ratio:
32.89x
Volume:
114K
Avg. volume:
271.5K
1-year change:
-59.21%
Market cap:
$51.2M
Revenue:
$69.3M
EPS (TTM):
-$0.89
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
TELA
TELA Bio, Inc.
|
$21.8M | -$0.20 | 19.22% | -20.8% | $3.45 |
|
ELMD
Electromed, Inc.
|
$16.6M | -- | 11.04% | -- | $36.00 |
|
IRIX
IRIDEX Corp.
|
$12.8M | -$0.12 | -2.72% | -18.18% | -- |
|
MYO
Myomo, Inc.
|
$9.4M | -$0.11 | -13.8% | -1168.66% | $5.00 |
|
PAHC
Phibro Animal Health Corp.
|
$345.4M | $0.60 | 15% | 756.68% | $43.00 |
|
STXS
Stereotaxis, Inc.
|
$8.4M | -$0.06 | 43.53% | -30.79% | $4.25 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
TELA
TELA Bio, Inc.
|
$1.15 | $3.45 | $51.2M | -- | $0.00 | 0% | 0.66x |
|
ELMD
Electromed, Inc.
|
$29.60 | $36.00 | $246.9M | 31.85x | $0.00 | 0% | 3.95x |
|
IRIX
IRIDEX Corp.
|
$0.99 | -- | $17M | -- | $0.00 | 0% | 0.33x |
|
MYO
Myomo, Inc.
|
$1.05 | $5.00 | $40.4M | -- | $0.00 | 0% | 1.03x |
|
PAHC
Phibro Animal Health Corp.
|
$40.15 | $43.00 | $1.6B | 24.14x | $0.12 | 1.2% | 1.17x |
|
STXS
Stereotaxis, Inc.
|
$2.37 | $4.25 | $221.2M | -- | $0.00 | 0% | 6.99x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
TELA
TELA Bio, Inc.
|
96.43% | 5.748 | 69.9% | 2.43x |
|
ELMD
Electromed, Inc.
|
-- | 1.217 | -- | 4.58x |
|
IRIX
IRIDEX Corp.
|
50.55% | 0.834 | 18.81% | 1.03x |
|
MYO
Myomo, Inc.
|
45.68% | -2.855 | 35.87% | 1.94x |
|
PAHC
Phibro Animal Health Corp.
|
71.58% | 2.736 | 47.87% | 1.12x |
|
STXS
Stereotaxis, Inc.
|
32.62% | 1.831 | 1.93% | 0.81x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
TELA
TELA Bio, Inc.
|
$14M | -$7.6M | -74.61% | -381.96% | -36.51% | -$5.9M |
|
ELMD
Electromed, Inc.
|
$13.2M | $2.7M | 18.88% | 18.89% | 15.81% | -$98K |
|
IRIX
IRIDEX Corp.
|
$4M | -$1.4M | -54.1% | -155.93% | -11.3% | -$1.2M |
|
MYO
Myomo, Inc.
|
$6.4M | -$3.5M | -46.49% | -68.35% | -34.86% | -$2.9M |
|
PAHC
Phibro Animal Health Corp.
|
$119.3M | $47.9M | 6.8% | 24.77% | 13.16% | -$4.5M |
|
STXS
Stereotaxis, Inc.
|
$4.1M | -$5.2M | -141.59% | -218.3% | -69.75% | -$4.2M |
TELA Bio, Inc. vs. Competitors
-
Which has Higher Returns TELA or ELMD?
Electromed, Inc. has a net margin of -41.58% compared to TELA Bio, Inc.'s net margin of 12.65%. TELA Bio, Inc.'s return on equity of -381.96% beat Electromed, Inc.'s return on equity of 18.89%.
Company Gross Margin Earnings Per Share Invested Capital TELATELA Bio, Inc.67.52% -$0.19 $43.6M ELMDElectromed, Inc.78.15% $0.25 $44.7M -
What do Analysts Say About TELA or ELMD?
TELA Bio, Inc. has a consensus price target of $3.45, signalling upside risk potential of 200%. On the other hand Electromed, Inc. has an analysts' consensus of $36.00 which suggests that it could grow by 21.62%. Given that TELA Bio, Inc. has higher upside potential than Electromed, Inc., analysts believe TELA Bio, Inc. is more attractive than Electromed, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TELATELA Bio, Inc.3 1 0 ELMDElectromed, Inc.4 0 0 -
Is TELA or ELMD More Risky?
TELA Bio, Inc. has a beta of 0.874, which suggesting that the stock is 12.592% less volatile than S&P 500. In comparison Electromed, Inc. has a beta of 0.259, suggesting its less volatile than the S&P 500 by 74.113%.
-
Which is a Better Dividend Stock TELA or ELMD?
TELA Bio, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TELA Bio, Inc. pays -- of its earnings as a dividend. Electromed, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TELA or ELMD?
TELA Bio, Inc. quarterly revenues are $20.7M, which are larger than Electromed, Inc. quarterly revenues of $16.9M. TELA Bio, Inc.'s net income of -$8.6M is lower than Electromed, Inc.'s net income of $2.1M. Notably, TELA Bio, Inc.'s price-to-earnings ratio is -- while Electromed, Inc.'s PE ratio is 31.85x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TELA Bio, Inc. is 0.66x versus 3.95x for Electromed, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TELATELA Bio, Inc.0.66x -- $20.7M -$8.6M ELMDElectromed, Inc.3.95x 31.85x $16.9M $2.1M
-
Which has Higher Returns TELA or IRIX?
IRIDEX Corp. has a net margin of -41.58% compared to TELA Bio, Inc.'s net margin of -12.6%. TELA Bio, Inc.'s return on equity of -381.96% beat IRIDEX Corp.'s return on equity of -155.93%.
Company Gross Margin Earnings Per Share Invested Capital TELATELA Bio, Inc.67.52% -$0.19 $43.6M IRIXIRIDEX Corp.32.15% -$0.09 $9.5M -
What do Analysts Say About TELA or IRIX?
TELA Bio, Inc. has a consensus price target of $3.45, signalling upside risk potential of 200%. On the other hand IRIDEX Corp. has an analysts' consensus of -- which suggests that it could grow by 102.68%. Given that TELA Bio, Inc. has higher upside potential than IRIDEX Corp., analysts believe TELA Bio, Inc. is more attractive than IRIDEX Corp..
Company Buy Ratings Hold Ratings Sell Ratings TELATELA Bio, Inc.3 1 0 IRIXIRIDEX Corp.0 0 0 -
Is TELA or IRIX More Risky?
TELA Bio, Inc. has a beta of 0.874, which suggesting that the stock is 12.592% less volatile than S&P 500. In comparison IRIDEX Corp. has a beta of 0.652, suggesting its less volatile than the S&P 500 by 34.842%.
-
Which is a Better Dividend Stock TELA or IRIX?
TELA Bio, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IRIDEX Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TELA Bio, Inc. pays -- of its earnings as a dividend. IRIDEX Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TELA or IRIX?
TELA Bio, Inc. quarterly revenues are $20.7M, which are larger than IRIDEX Corp. quarterly revenues of $12.5M. TELA Bio, Inc.'s net income of -$8.6M is lower than IRIDEX Corp.'s net income of -$1.6M. Notably, TELA Bio, Inc.'s price-to-earnings ratio is -- while IRIDEX Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TELA Bio, Inc. is 0.66x versus 0.33x for IRIDEX Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TELATELA Bio, Inc.0.66x -- $20.7M -$8.6M IRIXIRIDEX Corp.0.33x -- $12.5M -$1.6M
-
Which has Higher Returns TELA or MYO?
Myomo, Inc. has a net margin of -41.58% compared to TELA Bio, Inc.'s net margin of -36.3%. TELA Bio, Inc.'s return on equity of -381.96% beat Myomo, Inc.'s return on equity of -68.35%.
Company Gross Margin Earnings Per Share Invested Capital TELATELA Bio, Inc.67.52% -$0.19 $43.6M MYOMyomo, Inc.63.84% -$0.09 $26.9M -
What do Analysts Say About TELA or MYO?
TELA Bio, Inc. has a consensus price target of $3.45, signalling upside risk potential of 200%. On the other hand Myomo, Inc. has an analysts' consensus of $5.00 which suggests that it could grow by 376.19%. Given that Myomo, Inc. has higher upside potential than TELA Bio, Inc., analysts believe Myomo, Inc. is more attractive than TELA Bio, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TELATELA Bio, Inc.3 1 0 MYOMyomo, Inc.4 0 0 -
Is TELA or MYO More Risky?
TELA Bio, Inc. has a beta of 0.874, which suggesting that the stock is 12.592% less volatile than S&P 500. In comparison Myomo, Inc. has a beta of 1.026, suggesting its more volatile than the S&P 500 by 2.583%.
-
Which is a Better Dividend Stock TELA or MYO?
TELA Bio, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Myomo, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TELA Bio, Inc. pays -- of its earnings as a dividend. Myomo, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TELA or MYO?
TELA Bio, Inc. quarterly revenues are $20.7M, which are larger than Myomo, Inc. quarterly revenues of $10.1M. TELA Bio, Inc.'s net income of -$8.6M is lower than Myomo, Inc.'s net income of -$3.7M. Notably, TELA Bio, Inc.'s price-to-earnings ratio is -- while Myomo, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TELA Bio, Inc. is 0.66x versus 1.03x for Myomo, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TELATELA Bio, Inc.0.66x -- $20.7M -$8.6M MYOMyomo, Inc.1.03x -- $10.1M -$3.7M
-
Which has Higher Returns TELA or PAHC?
Phibro Animal Health Corp. has a net margin of -41.58% compared to TELA Bio, Inc.'s net margin of 7.29%. TELA Bio, Inc.'s return on equity of -381.96% beat Phibro Animal Health Corp.'s return on equity of 24.77%.
Company Gross Margin Earnings Per Share Invested Capital TELATELA Bio, Inc.67.52% -$0.19 $43.6M PAHCPhibro Animal Health Corp.32.8% $0.65 $1.1B -
What do Analysts Say About TELA or PAHC?
TELA Bio, Inc. has a consensus price target of $3.45, signalling upside risk potential of 200%. On the other hand Phibro Animal Health Corp. has an analysts' consensus of $43.00 which suggests that it could grow by 7.1%. Given that TELA Bio, Inc. has higher upside potential than Phibro Animal Health Corp., analysts believe TELA Bio, Inc. is more attractive than Phibro Animal Health Corp..
Company Buy Ratings Hold Ratings Sell Ratings TELATELA Bio, Inc.3 1 0 PAHCPhibro Animal Health Corp.0 2 0 -
Is TELA or PAHC More Risky?
TELA Bio, Inc. has a beta of 0.874, which suggesting that the stock is 12.592% less volatile than S&P 500. In comparison Phibro Animal Health Corp. has a beta of 0.771, suggesting its less volatile than the S&P 500 by 22.868%.
-
Which is a Better Dividend Stock TELA or PAHC?
TELA Bio, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Phibro Animal Health Corp. offers a yield of 1.2% to investors and pays a quarterly dividend of $0.12 per share. TELA Bio, Inc. pays -- of its earnings as a dividend. Phibro Animal Health Corp. pays out 40.46% of its earnings as a dividend. Phibro Animal Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios TELA or PAHC?
TELA Bio, Inc. quarterly revenues are $20.7M, which are smaller than Phibro Animal Health Corp. quarterly revenues of $363.9M. TELA Bio, Inc.'s net income of -$8.6M is lower than Phibro Animal Health Corp.'s net income of $26.5M. Notably, TELA Bio, Inc.'s price-to-earnings ratio is -- while Phibro Animal Health Corp.'s PE ratio is 24.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TELA Bio, Inc. is 0.66x versus 1.17x for Phibro Animal Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TELATELA Bio, Inc.0.66x -- $20.7M -$8.6M PAHCPhibro Animal Health Corp.1.17x 24.14x $363.9M $26.5M
-
Which has Higher Returns TELA or STXS?
Stereotaxis, Inc. has a net margin of -41.58% compared to TELA Bio, Inc.'s net margin of -86.59%. TELA Bio, Inc.'s return on equity of -381.96% beat Stereotaxis, Inc.'s return on equity of -218.3%.
Company Gross Margin Earnings Per Share Invested Capital TELATELA Bio, Inc.67.52% -$0.19 $43.6M STXSStereotaxis, Inc.54.94% -$0.07 $17.1M -
What do Analysts Say About TELA or STXS?
TELA Bio, Inc. has a consensus price target of $3.45, signalling upside risk potential of 200%. On the other hand Stereotaxis, Inc. has an analysts' consensus of $4.25 which suggests that it could grow by 79.33%. Given that TELA Bio, Inc. has higher upside potential than Stereotaxis, Inc., analysts believe TELA Bio, Inc. is more attractive than Stereotaxis, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TELATELA Bio, Inc.3 1 0 STXSStereotaxis, Inc.3 0 0 -
Is TELA or STXS More Risky?
TELA Bio, Inc. has a beta of 0.874, which suggesting that the stock is 12.592% less volatile than S&P 500. In comparison Stereotaxis, Inc. has a beta of 1.472, suggesting its more volatile than the S&P 500 by 47.244%.
-
Which is a Better Dividend Stock TELA or STXS?
TELA Bio, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Stereotaxis, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TELA Bio, Inc. pays -- of its earnings as a dividend. Stereotaxis, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TELA or STXS?
TELA Bio, Inc. quarterly revenues are $20.7M, which are larger than Stereotaxis, Inc. quarterly revenues of $7.5M. TELA Bio, Inc.'s net income of -$8.6M is lower than Stereotaxis, Inc.'s net income of -$6.5M. Notably, TELA Bio, Inc.'s price-to-earnings ratio is -- while Stereotaxis, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TELA Bio, Inc. is 0.66x versus 6.99x for Stereotaxis, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TELATELA Bio, Inc.0.66x -- $20.7M -$8.6M STXSStereotaxis, Inc.6.99x -- $7.5M -$6.5M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Are the Best AI Power Stocks?
As the construction of AI infrastructure accelerates, the gap between…
Is IONQ The Best Quantum Stock to Buy?
Riding a wave of investor enthusiasm for the technology, quantum…
Stock Ideas
Sell
47
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 60x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
71
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
42
OKLO alert for Dec 16
Oklo, Inc. [OKLO] is down 5.81% over the past day.
Sell
48
SEI alert for Dec 16
Solaris Energy Infrastructure, Inc. [SEI] is down 5.3% over the past day.
Sell
50
SMX alert for Dec 16
SMX (Security Matters) Plc [SMX] is down 21.85% over the past day.
